Invitrogen™ Vivofectamine™ Delivery Solutions
The most trusted delivery brand now offering cutting-edge lipid nanoparticle (LNP) solutions with proven safety, delivery efficiency and specificity for your nucleic acid drug delivery needs.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Thermo Fisher Scientific have dedicated over 30 years of innovation on curating our chemically diverse lipid library to empower you in a variety of therapeutic applications.
Generating high-quality mRNA-LNP complexes for in vivo delivery: Strategies and methods
Thursday, May 29, 2025 - 9:30 IST | 12:00 SGT | 13:00 KST, JST | 14:00 AEST
The production of high-quality mRNA for therapeutic applications presents several challenges, including yield limitation, low capping efficiency, stability concerns, and immunogenicity issues. In fact, crude mRNA preparations can trigger transient inflammatory responses, complicating their use in clinical settings.
In this expert webinar, we will discuss the latest advancements in mRNA synthesis, purification, and delivery technologies that are helping to overcome these barriers. This session will provide a practical walkthrough of using the mMESSAGE mMACHINE T7 mRNA Kit with CleanCap Reagent AG to achieve efficient co-transcriptional capping and generate high-yield, high-purity mRNA with minimal immunogenic contaminants.
You’ll also discover how Vivofectamine delivery solutions are utilized to encapsulate mRNA into lipid nanoparticles (LNPs) for stable and targeted in vivo delivery. We’ll highlight methods to assess the performance, expression, and immunogenic profile of these mRNA-LNP complexes through in vitro and in vivo assays, including luciferase reporter expression in mouse models.
Key learning objectives:
- Learn key steps in mRNA synthesis and purification
- Discover basic concepts and components in the formulation of LNPs
- Gain practical insights and protocols to enhance the efficacy and safety of mRNA-based treatments
Who should attend?
Researchers and professionals involved in mRNA therapeutics or applications.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
